1. 71PImmunomodulatory germline variation impacts the development of multiple primary melanoma (MPM). (23rd October 2018) Authors: Ferguson, R; Archambault, A; Simpson, D; Kazlow, E; Lax, R; Moran, U; Wilson, M A; Shapiro, R; Pavlick, A; Osman, I; Polsky, D; Kirchhoff, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease. (2nd January 2015) Authors: Jolles, S; Orange, J S; Gardulf, A; Stein, M R; Shapiro, R; Borte, M; Berger, M Journal: Clinical and experimental immunology Issue: Volume 179:Number 2(2015:Feb.) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗